There were 1,601 press releases posted in the last 24 hours and 431,074 in the last 365 days.

BioScrip Buys Critical Homecare Solutions

March 26, 2010 (FinancialWire) — BioScrip, Inc. (NASDAQ: BIOS) said it has completed its acquisition of Critical Homecare Solutions Holdings, Inc., a provider of home infusion and home nursing products and services to patients suffering from chronic and acute medical conditions.

Under the terms of the transaction, BioScrip acquired CHS for a total of $237.9 million in cash and $109.8 million of BioScrip common stock, or approximately 13.1 million shares (based on BioScrip’s closing stock price of $8.37 on Wednesday, March 24, 2010).

BioScrip also issued to CHS shareholders around 3.40 million warrants having a $10.00 exercise price and a five-year term.

In connection with this acquisition, BioScrip said it has entered into a new senior credit facility for an aggregate amount of $150 million, consisting of a $100 million senior secured term loan and a $50 million senior secured revolving credit facility, both with a term of five years.

The company also issued $225.0 million of 10?% senior unsecured notes due October 1, 2015 in an unregistered offering.

Richard H. Friedman, chairman and CEO of BioScrip, said, “The combination of CHS and BioScrip represents a significant step forward in our strategy to become the clinical leader in the management of the chronically ill across all drug delivery technologies.”

He added that BioScrip will now have over 120 points of service including 33 Community Service Centers, 61 Specialty Infusion Pharmacies, three Mail Order Pharmacies and 33 Nursing locations, and operate in all 50 states with more than 1,000 managed care contracts.

New York-based BioScrip is a specialty pharmaceutical healthcare organization.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.